Enveric Biosciences, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Enveric Biosciences, Inc. reported Cash And Cash Equivalents At Carrying Value of $431.4 thousand for the year ending 2019.

  • Enveric Biosciences, Inc. showed a decrease of -68.5% in Cash And Cash Equivalents At Carrying Value from 2018 to 2019.
  • This data is from Enveric Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 25, 2020.
  • XBRL data for this metric is available from 2009 to 2019 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 11 years of available data (2009 to 2019), Enveric Biosciences, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 23,973.7%.
  • Historical annual values: Fiscal year 2019: $431.4 thousand | Fiscal year 2018: $1.37 million | Fiscal year 2017: $4.88 million | Fiscal year 2016: $1.38 million | Fiscal year 2015: $1.88 million | Fiscal year 2014: $5.1 thousand | Fiscal year 2013: $249.00 | Fiscal year 2012: $1.4 thousand | Fiscal year 2011: $18.2 thousand | Fiscal year 2010: $1.1 thousand | Fiscal year 2009: $1.8 thousand.
  • Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: